ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.944
0.00%
Brent Oil
84.025
0.58%
Bitcoin
57,813.44
-0.73%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Elevation Oncology Inc (ELEV)

  7. Elevation Oncology Inc (ELEV) Noticias

ELEV Elevation Oncology Inc

4.00
0.00 (0.00%)
Pre Mercado
Última actualización: 03:16:46
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Elevation Oncology Inc ELEV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 4.00 03:16:46
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/4/202415:30PRNUSElevation Oncology Presents Preclinical Proof-of-Concept..
06/3/202407:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202406:45EDGAR2Form 8-K - Current report
06/3/202406:30PRNUSElevation Oncology Reports Fourth Quarter and Full Year 2023..
06/3/202406:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202415:50PRNUSElevation Oncology to Present Preclinical Proof-of-Concept..
04/3/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/3/202406:30PRNUSElevation Oncology Appoints Experienced Clinical Development..
28/2/202406:30PRNUSElevation Oncology to Participate in Upcoming Investor..
22/2/202406:30PRNUSElevation Oncology Expands Ongoing Phase 1 Clinical Trial of..
20/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202415:15EDGAR2Form 8-K - Current report
22/1/202415:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
22/1/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202415:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/1/202406:45EDGAR2Form 8-K - Current report
22/1/202406:30PRNUSElevation Oncology Announces Appointment of Darcy Mootz,..
09/1/202415:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/1/202406:40EDGAR2Form 8-K - Current report
05/1/202406:30PRNUSElevation Oncology Announces Program Updates and Upcoming..
22/11/202306:30PRNUSElevation Oncology to Present at the Piper Sandler 35th..
02/11/202306:45EDGAR2Form 8-K - Current report
02/11/202306:30PRNUSElevation Oncology Reports Third Quarter 2023 Financial..
02/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/9/202315:30EDGAR2Form 8-K - Current report
05/9/202306:30PRNUSElevation Oncology to Present at the H.C. Wainwright 25th..
16/8/202306:45EDGAR2Form 8-K - Current report
16/8/202306:30PRNUSElevation Oncology Announces First Patient Dosed in the..
03/8/202306:45EDGAR2Form 8-K - Current report
03/8/202306:30PRNUSElevation Oncology Reports Second Quarter 2023 Financial..
03/8/202306:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/7/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202315:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/7/202307:15EDGAR2Form 8-K - Current report
13/7/202307:00PRNUSElevation Oncology Appoints Joseph Ferra as Chief Executive..
08/6/202321:41PRNUSElevation Oncology Announces Pricing of $50 Million Public..
08/6/202315:01PRNUSElevation Oncology Announces Launch of Proposed Public..
03/6/202308:00PRNUSElevation Oncology Highlights First-in-Human Phase 1..
15/5/202306:30PRNUSElevation Oncology Reports First Quarter 2023 Financial..

Su Consulta Reciente

NASDAQ
ELEV
Elevation Oncology
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados